David B. Barnett

661 total citations
17 papers, 453 citations indexed

About

David B. Barnett is a scholar working on Molecular Biology, Animal Science and Zoology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David B. Barnett has authored 17 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Animal Science and Zoology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in David B. Barnett's work include Receptor Mechanisms and Signaling (7 papers), Pharmacological Effects and Assays (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). David B. Barnett is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Pharmacological Effects and Assays (4 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). David B. Barnett collaborates with scholars based in United Kingdom, Netherlands and Austria. David B. Barnett's co-authors include M. D. Rawlins, Andrew Stevens, William B. Campbell, Steven D. Pearson, Brigitte Bloechl‐Daum, Éric Abadie, Franz König, Hans‐Georg Eichler, Stefan R. Nahorski and Malcolm I. Levene and has published in prestigious journals such as The Lancet, Nature Reviews Drug Discovery and Trends in Pharmacological Sciences.

In The Last Decade

David B. Barnett

17 papers receiving 418 citations

Peers

David B. Barnett

PPCH

GHP

CCM

Hubertus G. M. Leufkens Netherlands

Maria Raikou United Kingdom

Kenneth J. Skeith Canada

Dileep Kumar Rohra Pakistan

Jyotsna Mehta United States

Denise Finley United States

Øyvind Melien Norway

Christopher‐Paul Milne United States

Ameeta Parekh United States

D Schröder-Bernhardi Germany

Hubertus G. M. Leufkens Netherlands

David B. Barnett

182 ×0.9

73 ×1.0

PPCH

51 ×0.8

GHP

46 ×0.8

101 ×1.7

CCM

Citations per year, relative to David B. Barnett David B. Barnett (= 1×) peers Hubertus G. M. Leufkens

Countries citing papers authored by David B. Barnett

Since Specialization

Citations

This map shows the geographic impact of David B. Barnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Barnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Barnett more than expected).

Fields of papers citing papers by David B. Barnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Barnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Barnett. The network helps show where David B. Barnett may publish in the future.

Co-authorship network of co-authors of David B. Barnett

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Barnett. A scholar is included among the top collaborators of David B. Barnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Barnett. David B. Barnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Eichler, Hans‐Georg, Brigitte Bloechl‐Daum, Éric Abadie, et al.. (2010). Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers. Nature Reviews Drug Discovery. 9(4). 277–291. 104 indexed citations

Rawlins, M. D., David B. Barnett, & Andrew Stevens. (2009). Pharmacoeconomics: NICE's approach to decision‐making. British Journal of Clinical Pharmacology. 70(3). 346–349. 112 indexed citations

Campbell, William B. & David B. Barnett. (2004). The governance of innovation. British journal of surgery. 91(12). 1536–1537. 46 indexed citations

Downie, Paul, Suneel Talwar, Iain Squire, et al.. (1999). Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction. Clinical Science. 97(3). 255–258. 38 indexed citations

Barnett, David B.. (1993). Flosequinan. The Lancet. 341(8847). 733–736. 10 indexed citations

Mistry, Rajendra, et al.. (1993). In Vivo Regulation of Human Cardiac β-Adrenoceptors by a Partial Agonist as Compared with a Full Antagonist. Journal of Cardiovascular Pharmacology. 22(3). 481–487. 1 indexed citations

Mistry, Rajendra, et al.. (1993). Subtype selective regulation of coupling of rat cardiac ß adrenoceptors to adenylate cyclase. European Journal of Pharmacology Molecular Pharmacology. 245(3). 285–289. 6 indexed citations

Levene, Malcolm I., et al.. (1990). The Use Of A Calcium‐Channel Blocker, Nicardipine, For Severely Asphyxiated Newborn Infants. Developmental Medicine & Child Neurology. 32(7). 567–574. 60 indexed citations

Nahorski, Stefan R., et al.. (1987). Human platelet β₂‐adrenoceptors: agonist‐induced internalisation and down‐regulation in intact cells. British Journal of Pharmacology. 92(3). 587–596. 10 indexed citations

10.

Barnett, David B.. (1985). Antifibrinolytic Drugs: Chemistry, Pharmacology and Clinical Usage. Postgraduate Medical Journal. 61(719). 846–846. 6 indexed citations

11.

Nahorski, Stefan R., et al.. (1985). (−)-[125I]Pindolol binding to the human platelet β-adrenoceptor: Characterisation and agonist interactions. European Journal of Pharmacology. 113(2). 247–254. 9 indexed citations

12.

Wood, J. K., et al.. (1984). Human platelet α2-adrenoceptors: Relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals. European Journal of Pharmacology. 103(1-2). 25–32. 13 indexed citations

13.

Barnett, David B., et al.. (1984). Interactions of endogenous and exogenous norepinephrine with alpha2 adrenoceptor binding sites in rat cerebral cortex. Biochemical Pharmacology. 33(8). 1293–1298. 19 indexed citations

14.

Freemont, Anthony J., et al.. (1983). Pericarditis and Arthritis Complicating Chickenpox. International Journal of Clinical Practice. 37(6). 226–227. 5 indexed citations

15.

Barnett, David B. & S. R. Nahorski. (1983). Drug assays in plasma by radioreceptor techniques. Trends in Pharmacological Sciences. 4. 407–409. 8 indexed citations

16.

O'Malley, B P, R J Abbott, David B. Barnett, B. J. Northover, & F. D. Rosenthal. (1982). PROPRANOLOL VERSUS CARBIMAZOLE AS THE SOLE TREATMENT FOR THYROTOXICOSIS. A CONSIDERATION OF CIRCULATING THYROID HORMONE LEVELS AND TISSUE THYROID FUNCTION. Clinical Endocrinology. 16(6). 545–552. 5 indexed citations

17.

Barnett, David B., et al.. (1982). HETEROGENEITY OF β‐ADRENORECEPTOR SUBTYPES IN THE HUMAN PLACENTA. Journal of Autonomic Pharmacology. 2(2). 103–110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact